Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Biomarker Remove
Related Tags


December 2014
Th We Tu Mo Su Sa Fr
25 24 23 22 21 20 19

biomarker Press Releases

  + XML/RSS  



By Pathology Diagnostics Ltd
Pathology Diagnostics Ltd (PDL) has experienced recent company growth in size and structure, moving to new premises with state of the art laboratory facilities.

By Pharmatech Inc.
Development of Oncology Clinical Trials in the Time of Precision, Personalized Medicine

By Cambridge Healthtech Institute
Building an Investigational Program to Establish the Clinical Value of a Test, part of Molecular Medicine Tri-Conference 2014, will be held on February 9 in San Francisco.

By SomaLogic, Inc.
Executive search firm Sanford Rose Associates - Toft Group is pleased to announce another successful placement.

By Cambridge Healthtech Institute
New, expanded format includes 2 day and a half conferences presenting the points of view of all stakeholders involved in the process of companion diagnostic test design, manufacturing, clinical implementation and reimbursement.

By SMi Group
Join SMi Group in January 2013 London to discover the latest developments in compound screening and toxicity testing to companion diagnostic assays at our 6th annual Biomarkers Summit.

All Press Releases

By Pathology Diagnostics Ltd
Pathology Diagnostics Ltd (PDL) has experienced recent company growth in size and structure, moving to new premises with state of the art laboratory facilities.

By Pathology Diagnostics Ltd
Solving the problem of PD-L1 measurement using antibody based techniques.

By Pathology Diagnostics Ltd
Due to the recent rapid growth of Pathology Diagnostics, the advanced laboratory staining biomarker test portfolio of the organisation has grown at an extremely impressive rate, with the number of biomarkers validated now reaching over 370.

By Pharmatech Inc.
Exciting new data acquisition will lead to impressive results for Pharmatech's biomarker database

By Pharmatech Inc.
Development of Oncology Clinical Trials in the Time of Precision, Personalized Medicine

By Cambridge Healthtech Institute
Building an Investigational Program to Establish the Clinical Value of a Test, part of Molecular Medicine Tri-Conference 2014, will be held on February 9 in San Francisco.

By SomaLogic, Inc.
Executive search firm Sanford Rose Associates - Toft Group is pleased to announce another successful placement.

By Cambridge Healthtech Institute
New, expanded format includes 2 day and a half conferences presenting the points of view of all stakeholders involved in the process of companion diagnostic test design, manufacturing, clinical implementation and reimbursement.

By SMi Group
Join SMi Group in January 2013 London to discover the latest developments in compound screening and toxicity testing to companion diagnostic assays at our 6th annual Biomarkers Summit.

By Cambridge Healthtech Institute
CHI’s Event Short Course is being held at the Molecular Med TRI-CON 2012 on February 20th at The Moscone North Convention Center in San Francisco.

By Biomiga Diagnostics
Biomiga Diagnostics, maker of quantitative point-of-care tests for Therapeutic Drug Monitoring and biomarker testing to promote personalized medicine, today announced it is joining Astia, a global network serving women-led high growth start-ups.

By GTCbio
J. Carmel Egan, Vice President of Project Management at Eli Lilly and Company, to give a plenary keynote presentation at 7th Modern Drug Discovery and Development Summit (Oct 19-21, 2011 in San Diego, CA)

By Eileen Zhao
Charles R. Cantor, Chief Scientific Officer at Sequenom and Member of the US National Academy of Sciences, to give a plenary keynote presentation at the 7th Modern Drug Discovery and Development Summit (Oct 19-21, 2011 in San Diego, CA)

By Fast Market Research
New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research

By Insight Pharma Reports
Insight Pharma Reports Announces 2011 Report Titles

By SMi Group
SMi Biomarkers - LAST CHANCE TO ATTEND! Dieses Bild im Großformat speichern (openPR) - Biomarkers Summit Biomarker Discovery, Validation and Qualification 31st January to 1st February 2011, Crowne Plaza - The City, London, United Kingdom

By SMi Group
SMi present their 4th annual Biomarkers Summit Monday 31st January & Tuesday 1st February 2011, Crowne Plaza City, Central London, UK Sponsored by: Caprotec, Cell Signalling Technology, Genstruct, Millipore, RBM, Quest Diagnostics

By Mark Warne, CEO
UCB seeking to understand cell signalling mechanisms of therapeutic antibodies enabling identification of biomarkers

By RayBiotech, Inc.
RayBiotech, Inc., announced today it will renew its Biomarker Discovery Pilot Grant program for 2011 and will accept applications for restricted pilot grants of $5,000 to $20,000 worth of RayBiotech products and/or services beginning in early 2011.

By Bharatbook
Bharatbook added a new report on "Central Nervous System (CNS) Biomarkers: Technologies and Global Markets" which assess the global CNS biomarker market and make forecasts from 2010 to 2015.

By RayBiotech, Inc.
RayBiotech, Inc., a leading developer and supplier of multiplex protein and antibody arrays, was recently awarded an STTR research grant to identify protein markers that could potentially be used in a diagnostic test for endometriosis.

By SMi Group Ltd.
Monday 31st January & Tuesday 1st February 2011 Crown Plaza City, London, www.smi-online.co.uk/preclinical-biomarkers.asp

By Fast Market Research
Fast Market Research recommends "Advances in Imaging Biomarkers: Innovative technologies, applications in R&D and clinical practice, and informatics and regulatory requirements" from Business Insights, now available

By MarketResearch.com
MarketResearch.com has announced the addition of “How to Enhance the Value of Antiviral Therapies Through Biomarkers and Diagnostics.” This report focuses on how recent R&D innovations in biomarker diagnostics are improving antiviral treatments

By RayBiotech, Inc.
RayBiotech announced the recipients of its Biomarker Discovery Grants. By sponsoring these awards, RayBiotech intends to demonstrate that any researcher with a modest research budget can discover disease-related biomarkers using its antibody arrays.

By Fast Market Research
Fast Market Research recommends "Global Oncology Biomarker Market" from Markets and Markets, now available

By Fast Market Research
Recently published research from Business Insights, "Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook", is now available at Fast Market Research

By ReportsandReports
This report reviews various biomarker technologies and therapy area applications. Market drivers and restraints are viewed in the context of biomarker activity of leading innovator companies as well as contract research organizations.

By Richard de Silva
Advancements continue to be made in the use of biomarkers to predict the growth of cancerous cells as London conference gears up to aid the process of clinical development in the field of Oncology.

By RayBiotech, Inc.
RayBiotech, Inc., today announced that they are extending the deadline for submitting applications for its Biomarker Discovery Pilot Grant program. RayBiotech will now accept applications for the pilot grants through February 22nd, 2010.

By Micromedic Technologies Ltd.
Micromedic Technologies LTD, the sponsor of Prof. Arber's study demonstrating CD24 as a biomarker for colorectal cancer, is proud to report that the ASCO has selected the study as one of four most important and promising studies for 2009.

By RayBiotech, Inc.
RayBiotech today announced the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services for protein biomarker discovery.

By Burton Lee
Lee Biosolutions is involved with the development and purification of the next generation of cardiovascular biomarkers that has the potential of not only improving but also the ability to better treat patients with chronic and acute heart failure.

By MarketsandMarkets
The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014, driven by the high demand for the biomarkers in the field of drug discovery.

By Ocimum Biosolutions
Global alliance enables gene expression profiling from challenging clinical samples

By Mayank Kumar
Ocimum Biosolutions now offers complete sequencing solution to all reserach , pharma and biotech laboratories

By GTCbio
GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida.

By Elements PR
Cambridge Research Biochemicals (CRB) has signed an agreement with Panagene to become the UK distributor for high purity peptide nucleic acids (PNA) oligomers. PNAs have many applications in bio-procedures, diagnostics, and anti-gene therapies.

By Lee Biosolutions
C-Reactive Protein is a protein found in the blood that operates as a marker for inflammation, meaning its presence indicates an increased state of inflammation in the body. Lee Biosolutions is a preferred supplier for the clinical diagnostic market

By GTCbio
Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008.



Page:
  • 1

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share